Dolby Laboratories, Inc.
General ticker "DLB" information:
- Sector: Information Technology
- Industry: Information Technology Services
- Capitalization: $5.9B (TTM average)
Dolby Laboratories, Inc. does not follow the US Stock Market performance with the rate: -15.4%.
Estimated limits based on current volatility of 1.4%: low 58.66$, high 60.33$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-08-11, amount 0.36$ (Y2.40%)
- Total employees count: 2051 (-1.4%) as of 2025
- US accounted for 36.8% of revenue in the fiscal year ended 2025-09-26
- Top business risk factors: Changing content trends, Cinema industry conditions, Competitor technological advantage, Economic downturns and volatility, Supply chain disruptions
- Current price 17.0% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-26 to 2027-09-26
- 2025-09-26 to 2026-09-26 estimated range: [65.99$, 87.89$]
- 2026-09-26 to 2027-09-26 estimated range: [72.25$, 94.70$]
Financial Metrics affecting the DLB estimates:
- Positive: with PPE of 16.9 at the end of fiscal year the price was neutral
- Positive: 15.80 < Operating profit margin, % of 19.64
- Positive: 6.77 < Operating cash flow per share per price, % of 6.85
- Positive: 7.19 < Return on assets ratio (scaled to [-100,100]) of 7.36
- Negative: Industry operating cash flow per share per price (median), % of 0.99 <= 3.66
- Negative: 69.38 < Shareholder equity ratio, % of 81.25 <= 81.92
- Positive: -4.55 < Industry operating profit margin (median), % of -3.83
- Negative: Investing cash flow per share per price, % of -0.15 <= -0.14
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term DLB quotes
Long-term DLB plot with estimates
Financial data
| YTD | 2023-09-29 | 2024-09-27 | 2025-09-26 |
|---|---|---|---|
| Operating Revenue | $1,299.74MM | $1,273.72MM | $1,349.13MM |
| Operating Expenses | $1,083.99MM | $1,015.39MM | $1,084.17MM |
| Operating Income | $215.75MM | $258.33MM | $264.96MM |
| Non-Operating Income | $34.30MM | $54.15MM | $38.53MM |
| R&D Expense | $271.52MM | $263.66MM | $261.79MM |
| Income(Loss) | $250.05MM | $312.48MM | $303.49MM |
| Taxes | $48.41MM | $48.16MM | $46.99MM |
| Net Income(Loss)* | $200.66MM | $264.32MM | $255.02MM |
| Stockholders Equity | $2,355.10MM | $2,477.16MM | $2,622.56MM |
| Inventory | $35.62MM | $33.73MM | $30.42MM |
| Assets | $2,979.77MM | $3,109.93MM | $3,227.76MM |
| Operating Cash Flow | $367.08MM | $327.25MM | $472.20MM |
| Capital expenditure | $30.34MM | $30.01MM | $41.94MM |
| Investing Cash Flow | $54.21MM | $-286.29MM | $-10.59MM |
| Financing Cash Flow | $-236.81MM | $-287.81MM | $-247.24MM |
| Earnings Per Share** | $2.09 | $2.77 | $2.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.